Search

388 Result(s)
Sort by

Targeting Tumor Stroma

Targeting Tumor Stroma

Boehringer Ingelheim’s research approach in stromal biology may lead to new medicines that will change the face of cancer and give new hope to patients
Our Innovation Strategy

Our Innovation Strategy

A deep understanding of disease, identifying relevant mechanisms and choosing therapeutic modalities to address them is the core of our innovation strategy
Bowel Issues

Bowel Issues

Find out how to handle changes to bowel habits following cancer treatment from Taking Cancer On Through Flavour
Research Beyond Borders Partnering

Research Beyond Borders Partnering

Our Research Beyond Borders team is looking for emerging science and technology opportunities. Learn more about partnering with us.
Immunology

Immunology

We are looking for new early-science collaborations and invite you to join our expanding community of innovation partners in immunology.
Retinal Health

Retinal Health

Human Pharma Clinical Pipeline Retinal Health therapeutic area
Changes in Taste and Smell

Changes in Taste and Smell

Learn about the ways in which you can tackle changes in taste and smell from Taking Cancer On Through Flavour
A Unique Bond: he picked me

A Unique Bond: he picked me

After being diagnosed with cancer Helga has many tough decisions to make. An easy decision for her was to introduce Brumbi to the family.
Sore Mouth or Throat

Sore Mouth or Throat

Discover tips on how to take care of a sore mouth or throat from Taking Cancer On Through Flavour
Snacks

Snacks

Explore all of the sweet and savoury snack recipes from Taking Cancer on Through Flavour here.
Instant Pot Beef Stew Video

Instant Pot Beef Stew Video

A tender beef stew in a rich gravy made by Taking Cancer on Through Flavour and Taste Life. Find out how to make this recipe here.
Martin Stefanic

Martin Stefanic

Martin Stefanic, Patient Safety Therapeutic Area Head for Oncology, discusses his move to Patient Safety.
Immuno-Oncology

Immuno-Oncology

We are developing complementary platforms (including, T Cell Engagers, oncolytic viruses, and cancer vaccines), which have the potential to turn cold tumors hot, extending the benefits of immunotherapy to more people.